Interim Injunctions: AstraZeneca v Glenmark

Jane Lambert Court of Appeal (Lords Justices Coulson, Arnold and Warby) AstraZeneca AB and another v Glenmark Pharmaceuticals Europe Ltd [2025] EWCA Civ 480 (16 April 2025) This was an appeal against Michael Tappin KC's refusal in AstraZeneca AB and another v Glenmark Pharmaceuticals Europe Ltd (Re Interim Injunction Application) [2025] EWHC 748 (Pat) (28 March 2025) to grant AstraZeneca AB and AstraZeneca UK Ltd. an interim injunction to restrain Gelnmark Pharmaceuticals Europe Ltd. from selling a product containing dapagliflozin pending a hearing on the form of order following a trial to determine the validity of the first claimant's supplemental protection certificates for dapagliflozin and a combination of dapagliflozin and metformin. The appeal was heard by Lords Justices Coulson, Arnold and Warby on 9 April 2025. At the end of the hearing, the Lords Justices announced that they would allow AstraZeneca's appeal. Lord Justice ...